· · Single source ·Updated

Orforglipron pill helps menopausal and non-menopausal women lose weight

Researchers presented new analysis showing orforglipron promotes weight loss in women of all ages at the European Association for the Study of Diabetes meeting in Milan.

Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages
File photo Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages Photo: Healthline

Study covers different menopausal stages

An analysis of two prior trials found the medication works equally well regardless of a woman's hormonal status. The data included participants who had not yet gone through menopause, those currently experiencing it, and those who were postmenopausal.

Estrogen decline complicates weight management

Lower estrogen levels after menopause often cause weight gain, particularly around the midsection. This specific area of fat accumulation is linked to various health risks for women.

Pill form offers convenience

The new drug comes in a pill format which provides a convenient option for many patients. Doctors note that selecting the most effective treatment remains important for individual cases.

Reported by one outlet

Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.

Reported by

1 independent outlet. Headline as published. Links open the original report.